Adverse Effects and Antibody Titers in Response to the BNT162b2 mRNA COVID-19 Vaccine in a Prospective Study of Healthcare Workers
Abstract
The relationship between postvaccination symptoms and strength of antibody responses is unclear. The goal of this study was to determine whether adverse effects caused by vaccination with the Pfizer/BioNTech BNT162b2 vaccine are associated with the magnitude of vaccine-induced antibody levels.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Nov 20, 2021
- Source ID
- 10.1093/ofid/ofab575
Entities
People
- Allison M W Malloy
- Alyssa R Lindrose
- Anatalio E. Reyes
- Andrew G. Letizia
- Andrew L. Snow
- Belinda M. Jackson-thompson
- Cara Olsen
- Christopher A. Duplessis
- Christopher C Broder
- Daniel Ewing
- David R. Tribble
- Edward Mitre
- Edward Parmelee
- Emilie Goguet
- Emily C Samuels
- Eric D. Laing
- Gregory Wang
- John H. Powers
- Julian Davies
- Kathleen F Ramsey
- Kevin L Schully
- Luca Illinik
- Matthew Moser
- Mimi A Wong
- Monique Hollis-perry
- Orlando Ortega
- Santina E Maiolatesi
- Simon D. Pollett
- Si’ana A. Coggins
- Timothy H. Burgess
- Yolanda Alcorta
Organizations
- General Dynamics
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- National Cancer Institute
- National Institutes of Health
- Naval Medical Research Center
- Uniformed Services University of the Health Sciences
- United States Department of Defense